Receptor tyrosine kinase mutations in non-small cell lung cancer

被引：0
|
作者：
Hayashi, H. [1 ]
Togashi, Y. [2 ]
Terashima, M. [2 ]
Sakai, K. [2 ]
Mizuuchi, H. [3 ]
Kobayashi, Y. [3 ]
Suda, K. [3 ]
Nakagawa, K. [1 ]
Nishio, K. [2 ]
Mitsudomi, T. [3 ]
机构：
[1] Kinki Univ, Fac Med, Med Oncol, Osaka, Japan
[2] Kinki Univ, Fac Med, Genome Biol, Osaka, Japan
[3] Kinki Univ, Fac Med, Thorac Surg, Osaka, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31660-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3016
引用
收藏
页码：S601 / S601
页数：1
相关论文
共 50 条
  • [1] Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer
    Yang, SH
    Mechanic, LE
    Yang, P
    Landi, MT
    Bowman, ED
    Wampfler, J
    Meerzaman, D
    Hong, KM
    Mann, F
    Dracheva, T
    Fukuoka, J
    Travis, W
    Caporaso, NE
    Harris, CC
    Jen, A
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2106 - 2110
  • [2] Function of Axl receptor tyrosine kinase in non-small cell lung cancer (Review)
    Zhang, Guoan
    Wang, Meng
    Zhao, Hongli
    Cui, Wen
    [J]. ONCOLOGY LETTERS, 2018, 15 (03) : 2726 - 2734
  • [3] Multitargeted receptor tyrosine kinase inhibition: An antiangiogenic strategy in non-small cell lung cancer
    Socinski, Mark A.
    [J]. CANCER TREATMENT REVIEWS, 2011, 37 (08) : 611 - 617
  • [4] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [5] Tyrosine kinase inhibitors in the management of non-small cell lung cancer
    Perol, M.
    Arpin, D.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S188 - S197
  • [6] The Radiosensitivity of Tyrosine Kinase Driven Non-small Cell Lung Cancer
    Johung, K. L.
    Yu, J. B.
    Gettinger, S. N.
    Decker, R. H.
    Hess, J. A.
    Chiang, V. L.
    Contessa, J. N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S115 - S115
  • [7] Tyrosine Kinase Inhibitors and Epidermal Growth Factor Receptor (EGFR) Mutations in Non-Small Cell Lung Cancer To Test or Not to Test?
    Gazdar, Adi F.
    [J]. MEDICINE, 2011, 90 (03) : 168 - 170
  • [8] EGFR haplotypes confer risk for tyrosine kinase domain mutations in non-small cell lung cancer
    Liu, Wanqing
    He, Lijun
    Krishnaswamy, Soundararajan
    Kanteti, Rajani
    Wang, Yi-Ching
    Salgia, Ravi
    Ratain, Mark
    [J]. CANCER RESEARCH, 2009, 69
  • [9] Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer
    Vavala, Tiziana
    Mariniello, Annapaola
    Novello, Silvia
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S48 - S54
  • [10] Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: An analytical database
    Murray, Samuel
    Dahabreh, Issa J.
    Linardou, Helena
    Manoloukos, Menelaos
    Bafaloukos, Dimitrios
    Kosmidis, Paris
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 832 - 839
12345